Drotrecogin alfa (activated) in severe sepsis - Authors' reply

Andre C Kalil, Steven P. LaRosa

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)110-111
Number of pages2
JournalThe Lancet Infectious Diseases
Volume13
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Anti-Infective Agents
Protein C
Sepsis
drotrecogin alfa activated

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Drotrecogin alfa (activated) in severe sepsis - Authors' reply. / Kalil, Andre C; LaRosa, Steven P.

In: The Lancet Infectious Diseases, Vol. 13, No. 2, 01.02.2013, p. 110-111.

Research output: Contribution to journalLetter

@article{f8119d1dcec843dc9d89ef5906b41ee9,
title = "Drotrecogin alfa (activated) in severe sepsis - Authors' reply",
author = "Kalil, {Andre C} and LaRosa, {Steven P.}",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/S1473-3099(12)70350-X",
language = "English (US)",
volume = "13",
pages = "110--111",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Drotrecogin alfa (activated) in severe sepsis - Authors' reply

AU - Kalil, Andre C

AU - LaRosa, Steven P.

PY - 2013/2/1

Y1 - 2013/2/1

UR - http://www.scopus.com/inward/record.url?scp=84872574149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872574149&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(12)70350-X

DO - 10.1016/S1473-3099(12)70350-X

M3 - Letter

C2 - 23347628

AN - SCOPUS:84872574149

VL - 13

SP - 110

EP - 111

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 2

ER -